表4. MLL重排阳性患者EVI1表达、FAB分型、对手基因的分布和缓解率分析.
| 组别 | 例数 | FAB分型（例） |
染色体核型（例） |
CR率（%） | |||||||||
| M0 | M1 | M2 | M4 | M5 | t-AML | 未知 | t（11;19） | t（6;11） | t（9;11） | t（10;11） | |||
| EVI1基因高表达 | 22 | 1 | 3 | 3 | 2 | 12 | 1 | 0 | 6 | 9 | 2 | 2 | 36.7 |
| EVI1基因低表达 | 7 | 0 | 1 | 2 | 0 | 2 | 1 | 1 | 2 | 1 | 3 | 1 | 71.4 |
注：t-AML：治疗相关急性髓系白血病；CR：完全缓解
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.